Lung Cancer Clinical Trials in Albuquerque, NM

Lung Cancer Clinical Trials in Albuquerque, NM

View the best 10 lung cancer medical studies in Albuquerque, New Mexico. Access promising new therapies by applying to a Albuquerque-based Lung Cancer clinical trial.

Trials in Albuquerque, New Mexico

Here are the top 10 medical studies for lung cancer in Albuquerque, New Mexico

Image of Desert Hematology Oncology Medical Group, Inc. in Rancho Mirage, United States.

Cemiplimab +4 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2 & 3
This trial is testing a new drug called fianlimab with cemiplimab and chemotherapy in patients with advanced lung cancer. The goal is to see if this combination is more effective than current treatments. The new drugs help the immune system fight cancer, while chemotherapy attacks the cancer cells directly.
Image of Montefiore Medical Center - Moses Campus in Bronx, United States.

FSRS +1 More

Radiation Therapy

Recruiting1 award
This trial evaluates if a lower radiation dose over multiple days reduces side effects vs. one day of full radiation dose for cancer patients on immunotherapy.
Image of University of South Alabama /ID# 212939 in Mobile, United States.

Telisotuzumab Vedotin

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests telisotuzumab vedotin, a treatment that targets and kills cancer cells, in NSCLC patients with high c-Met levels. It aims to find the best patient group for this therapy and evaluate its safety and effectiveness. Telisotuzumab vedotin is a specialized treatment targeting c-Met-overexpressing tumor cells, and it has been evaluated in various studies for its safety and efficacy in treating advanced solid tumors, including non-small cell lung cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Surgery +2 More

Procedure

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of Mayo Clinic in Scottsdale, United States.

Datopotamab Deruxtecan +1 More

Antibody-Drug Conjugate

Recruiting1 awardPhase 1
This trial will study the safety and effectiveness of a new cancer drug when used alone or with another drug and chemotherapy.
Image of Mercy Hospital Fort Smith in Fort Smith, United States.

Afatinib Dimaleate

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2 & 3
This trial is studying afatinib dimaleate with or without cetuximab to treat patients with non-small cell lung cancer that has EGFR mutations.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Durvalumab

Monoclonal Antibodies

Recruiting2 awardsPhase 3
This trial is testing whether adding durvalumab to standard chemoradiation followed by additional durvalumab can extend patients life and/or prevent the tumor from coming back compared to the usual approach of chemoradiation alone followed by durvalumab.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Selpercatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial will study how well selpercatinib works in treating patients with RET fusion-positive non-small cell lung cancer. Selpercatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.